Pharmaceuticals News and Research

RSS

Abbott named one of Best Workplaces in Europe

The Great Place to Work Institute today named Abbott one of the Best Workplaces in Europe at its European Conference in Madrid. The company was specifically honored for workplace leadership in Denmark, Ireland and Norway.

20 May 2010

Cobalt Pharmaceuticals receives Notice of Compliance from Health Canada to market Atorvastatin Calcium Tablets

Watson Pharmaceuticals, Inc. today announced that its subsidiary Cobalt Pharmaceuticals has received a Notice of Compliance from Health Canada to market Atorvastatin Calcium Tablets in the 10, 20, 40 and 80 mg strengths. Watson has initiated shipments of this product.

20 May 2010

EPO rules in favor of Alnylam Pharmaceuticals’ Kreutzer-Limmer '945 patent

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the Board of Appeals of the European Patent Office (EPO) has ruled that claims of the Kreutzer-Limmer '945 (EP 1214945) patent meet needed requirements under European patent law. The '945 patent comprises broad claims covering the length and certain structural requirements for siRNAs that are important for advancement of RNAi therapeutics.

20 May 2010

Gene therapy shows positive effects in rat models of PAH: Researchers

Gene therapy has been shown to have positive effects in rat models of pulmonary arterial hypertension, according to researchers at the University of Adelaide in Australia.

20 May 2010

Lawsuit fears hinder physician adoption of medical innovations

According to a new national survey on defensive medicine by Jackson Healthcare, the threat of a lawsuit causes many physicians to delay the adoption of medical innovations. More than half (53%) of survey respondents reported they had delayed adopting medical innovations such as new pharmaceuticals, procedures and medical devices due to fear of litigation.

19 May 2010

Targacept commences Phase 2 clinical proof of concept trial of TC-5619 in adults with ADHD

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that it has initiated a Phase 2 clinical proof of concept trial of TC-5619 in adults with attention deficit/hyperactivity disorder (ADHD). TC-5619 is a novel small molecule that is highly selective for the alpha7 neuronal nicotinic receptor, which Targacept refers to as NNR, and was discovered by Targacept scientists using Targacept's proprietary drug discovery platform known as Pentad (TM).

19 May 2010

Results from Phase 1 clinical trials of TRC105, TRC102, and TRC093 to be presented at ASCO 2010

TRACON Pharmaceuticals, a biotechnology company that develops targeted therapies for oncology and ophthalmology, announced today that results from Phase 1 clinical trials of TRC105, TRC102, and TRC093 will be presented at the annual meeting of the American Society of Clinical Oncology on June 5-7, 2010 in Chicago, IL.

19 May 2010

BioTeknica, AccuReg help companies achieve realistic FDA compliance goals

Every year, the Food and Drug Administration (FDA), asks hundreds of life science companies to improve their design and manufacturing systems – or risk receiving the ultimate penalty – a Consent Decree; whereby a company must remove its products from the marketplace. It's not easy to navigate FDA regulations because they aren't always "black and white" – in fact; they're often "gray" and open to interpretation depending upon the circumstances.

19 May 2010

SBANE recognizes Isis Biopolymer with 2010 Rising Star Award

Isis Biopolymer has been awarded the 2010 Rising Star Award by SBANE (Smaller Business Association of New England). The Rising Star is a coveted annual award that honors innovative products and services offered by early-stage companies in New England.

19 May 2010

USPTO issues Soligenix patent for use of beclomethasone dipropionate in treatment of IBS

Soligenix, Inc., a late-stage biopharmaceutical company, announced today that the United States Patent Office (USPTO) has issued a patent (US 7,704,985) entitled "Treatment of Irritable Bowel Syndrome and Related Bowel Diseases." The patent claims the use of beclomethasone dipropionate (BDP) to treat irritable bowel syndrome (IBS), a painful gastrointestinal condition that affects approximately 15% of the population in the industrialized world.

19 May 2010

NeoStem, Vatican's Pontifical Council collaborate to expand raise awareness of adult stem cell therapies

NeoStem, Inc.,, an international biopharmaceutical company with operations in the US and China, and the Vatican's Pontifical Council for Culture, today announced a joint initiative that includes their charitable organizations to expand research and raise awareness of adult stem cell therapies.

19 May 2010

Study demonstrates need for understanding societal, economic impact of growing medicalization

Menopause. Normal pregnancy. Infertility. ADHD. Erectile dysfunction. Over the last several decades, these conditions have come to be defined and treated as medical problems. They've been "medicalized." In the first study of its kind in the current issue of Social Science and Medicine, Brandeis researchers used national data to estimate the costs of these and a handful of other common conditions on escalating U.S. healthcare spending.

19 May 2010

Vaccinations recommended for adults

Yearly vaccinations aren't just for kids any more. You probably heard a lot about a seasonal or H1N1 flu shot last fall, but you should know that a battery of other adult vaccinations might also become part of your health care routine. Pneumonia and shingles vaccines are preventive-care essentials for older adults, and meningitis and tetanus shots are now college rites of passage. Even the vaccines of childhood—measles, mumps and rubella, and whooping cough—are recommended for adults who missed out in their younger years.

19 May 2010

i3 completes acquisition of ChinaGate

i3, a global life sciences services company and subsidiary of Ingenix, has acquired ChinaGate, a contract research organization that provides product-development regulatory services for pharmaceutical, medical device and biotechnology companies looking to enter and access the Chinese market.

19 May 2010

TPP raises £9.6M to develop early-stage pre-clinical drug candidates

TPP Global Development, an innovative drug development company, announced today it has raised £9.6m which will be used to execute the Company's strategy to develop early-stage pre-clinical drug candidates.

19 May 2010

New multi-center follow-up study of NX-1207 for treatment of BPH to be completed

Nymox Pharmaceutical Corporation announced today that the Company is nearing completion of a new multi-center U.S. long-term follow-up study of NX-1207, its investigational drug for the treatment of benign prostatic hyperplasia.

19 May 2010

Opinions: Gender-based violence and HIV; AIDS vaccine; Global NTDs; Responses to NYT HIV/AIDS articles

"Gender-based violence is a world-wide pandemic and directly affects the spread of HIV/AIDS. Fear of violence limits the ability of women and girls to choose their partners; to find out about a partner's HIV status or disclose their own; and to get medical or counseling services," according to a U.S. government editorial in VOA News.

19 May 2010

BMJ News examines how drug resistance, access undermine malaria fight in Uganda, Cambodia

BMJ News looks at how lack of access to drugs and resistance are undermining the fight against malaria.

19 May 2010

Flibanserin benefits pre-menopausal women with Hypoactive Sexual Desire Disorder

Data from pivotal Phase III clinical trials demonstrate that a higher proportion of pre-menopausal women with Hypoactive Sexual Desire Disorder (HSDD) receiving flibanserin 100mg reported both an improvement in their condition and a meaningful benefit from their treatment, compared to placebo.

19 May 2010

Molecular Devices' foundational planar patch-clamp patent upheld by European Patent Office

Molecular Devices today announced that European Patent Office (EPO) has upheld Molecular Devices foundational planar patch-clamp patent (EP No 1 040 349 B1). The board will issue a written decision to this effect in the near future. The ruling will be the final determination of the EPO and cannot be appealed.

19 May 2010

Pharmaceuticals News and Research

Abbott named one of Best Workplaces in Europe

Cobalt Pharmaceuticals receives Notice of Compliance from Health Canada to market Atorvastatin Calcium Tablets

EPO rules in favor of Alnylam Pharmaceuticals’ Kreutzer-Limmer '945 patent

Gene therapy shows positive effects in rat models of PAH: Researchers

Lawsuit fears hinder physician adoption of medical innovations

Targacept commences Phase 2 clinical proof of concept trial of TC-5619 in adults with ADHD

Results from Phase 1 clinical trials of TRC105, TRC102, and TRC093 to be presented at ASCO 2010

BioTeknica, AccuReg help companies achieve realistic FDA compliance goals

SBANE recognizes Isis Biopolymer with 2010 Rising Star Award

USPTO issues Soligenix patent for use of beclomethasone dipropionate in treatment of IBS

NeoStem, Vatican's Pontifical Council collaborate to expand raise awareness of adult stem cell therapies

Study demonstrates need for understanding societal, economic impact of growing medicalization

Vaccinations recommended for adults

i3 completes acquisition of ChinaGate

TPP raises £9.6M to develop early-stage pre-clinical drug candidates

New multi-center follow-up study of NX-1207 for treatment of BPH to be completed

Opinions: Gender-based violence and HIV; AIDS vaccine; Global NTDs; Responses to NYT HIV/AIDS articles

BMJ News examines how drug resistance, access undermine malaria fight in Uganda, Cambodia

Flibanserin benefits pre-menopausal women with Hypoactive Sexual Desire Disorder

Molecular Devices' foundational planar patch-clamp patent upheld by European Patent Office

Drug Discovery - Second Edition eBook

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News